Paul Field
Patrimonio netto: 55 $ in data 31/10/2026
Patrimonio netto: 55 $ in data 31/10/2026
Paul Field was the founder of Bio-Link Partners Ltd., founded in 2005, where the title held was Executive Chairman from 2005 to 2014.
Current jobs include Independent Director at 60 Degrees Pharmaceuticals, Inc. since 2023 and Independent Non-Executive Director at Invion Ltd. starting in 2026.
Former job includes Director at Australian Institute of Co. Directors.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/07/2026 | 59 ( 0% ) | 55 $ | 31/10/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 12/07/2023 |
| INVION LIMITED | Direttore/Membro del Consiglio | 19/08/2026 |
| Società | Posizione | Fine |
|---|---|---|
Bio-Link Partners Ltd.
Bio-Link Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology business development company | Fondatore | 01/01/2014 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Bio-Link Partners Ltd.
Bio-Link Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology business development company | Commercial Services |
Invion Ltd.
Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale